Psychiatry Investig.  2017 Jan;14(1):58-62. 10.4306/pi.2017.14.1.58.

Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia

Affiliations
  • 1Department of Psychiatry, Dongguk University International Hospital, Goyang, Republic of Korea. ciw@duih.org
  • 2Institute of Clinical Psychopharmacology, Dongguk University College of Medicine, Goyang, Republic of Korea.
  • 3Department of Anesthesia & Pain Medicine, Dongguk University International Hospital, Goyang, Republic of Korea.

Abstract

OBJECTIVE: This retrospective case series study of the effectiveness of electroconvulsive therapy (ECT) augmentation on clozapine-resistant schizophrenia was conducted by EMR review.
METHODS
Clozapine-resistance was defined as persistent psychotic symptoms despite at least 12 weeks of clozapine administration with blood levels over 350 ng/mL in order to rule out pseudo-resistance. Seven in-patients who were taking clozapine and treated with ECT were selected. We analyzed the psychopathology and subscales changed by ECT.
RESULTS
The average number of ECT sessions was 13.4 (±4.6). Total Positive and Negative Syndrome Scale (PANSS) score was significantly reduced by 17.9 (±12.8) points (p=0.0384) on average, which represented a reduction of 25.5% (±14.3). 71.4% (5/7) of patients were identified as clinical remission, with at least a 20% reduction in PANSS score. PANSS reduction was associated with number of ECT sessions, stimulus level in the final session, and blood clozapine levels before ECT. However, the negative subscale on the PANSS were not reduced by ECT in any patient. We did not observe any persistent adverse cognitive effects.
CONCLUSION
This study supports that ECT augmentation on clozapine-resistant schizophrenia reveals clinically effective and safe. Further research should be done involving a larger number of patients to investigate the effectiveness of clozapine/ECT combination therapy.

Keyword

Clozapine-resistant schizophrenia; Electroconvulsive therapy; Augmentation
Full Text Links
  • PI
Share
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr